Adaptive metabolic and inflammatory responses identified using accelerated aging metrics are linked to adverse outcomes in severe SARS-CoV-2 infection
ABSTRACT INTRODUCTION Chronological age (CA) is a predictor of adverse COVID-19 outcomes; however, CA alone does not capture individual responses to SARS-CoV-2 infection. Here, we evaluated the influence of aging metrics PhenoAge and PhenoAgeAccel to predict adverse COVID-19 outcomes. Furthermore, we sought to model adaptive metabolic and inflammatory responses to severe SARS-CoV-2 infection using individual PhenoAge components.METHODS In this retrospective cohort study, we assessed cases admitted to a COVID-19 reference center in Mexico City. PhenoAge and PhenoAgeAccel were estimated using laboratory values at admission. Cox proportional hazards models were fitted to estimate risk for COVID-19 lethality and adverse outcomes (ICU admission, intubation, or death). To explore reproducible patterns which model adaptive responses to SARS-CoV-2 infection, we used k-means clustering using PhenoAge/PhenoAccelAge components.RESULTS We included 1068 subjects of whom 401 presented critical illness and 204 died. PhenoAge was a better predictor of adverse outcomes and lethality compared to CA and SpO2 and its predictive capacity was sustained for all age groups. Patients with responses associated to PhenoAgeAccel>0 had higher risk of death and critical illness compared to those with lower values (log-rank p<0.001). Using unsupervised clustering we identified four adaptive responses to SARS-CoV-2 infection: 1) Inflammaging associated with CA, 2) metabolic dysfunction associated with cardio-metabolic comorbidities, 3) unfavorable hematological response, and 4) response associated with favorable outcomes.CONCLUSIONS Adaptive responses related to accelerated aging metrics are linked to adverse COVID-19 outcomes and have unique and distinguishable features. PhenoAge is a better predictor of adverse outcomes compared to CA..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
bioRxiv.org - (2020) vom: 27. Nov. Zur Gesamtaufnahme - year:2020 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Márquez-Salinas, Alejandro [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
doi: |
10.1101/2020.11.03.20225375 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XBI019262426 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XBI019262426 | ||
003 | DE-627 | ||
005 | 20230429101232.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201106s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2020.11.03.20225375 |2 doi | |
035 | |a (DE-627)XBI019262426 | ||
035 | |a (DE-599)biorXiv10.1101/2020.11.03.20225375 | ||
035 | |a (biorXiv)10.1101/2020.11.03.20225375 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 |q DE-84 | |
100 | 1 | |a Márquez-Salinas, Alejandro |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adaptive metabolic and inflammatory responses identified using accelerated aging metrics are linked to adverse outcomes in severe SARS-CoV-2 infection |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a ABSTRACT INTRODUCTION Chronological age (CA) is a predictor of adverse COVID-19 outcomes; however, CA alone does not capture individual responses to SARS-CoV-2 infection. Here, we evaluated the influence of aging metrics PhenoAge and PhenoAgeAccel to predict adverse COVID-19 outcomes. Furthermore, we sought to model adaptive metabolic and inflammatory responses to severe SARS-CoV-2 infection using individual PhenoAge components.METHODS In this retrospective cohort study, we assessed cases admitted to a COVID-19 reference center in Mexico City. PhenoAge and PhenoAgeAccel were estimated using laboratory values at admission. Cox proportional hazards models were fitted to estimate risk for COVID-19 lethality and adverse outcomes (ICU admission, intubation, or death). To explore reproducible patterns which model adaptive responses to SARS-CoV-2 infection, we used k-means clustering using PhenoAge/PhenoAccelAge components.RESULTS We included 1068 subjects of whom 401 presented critical illness and 204 died. PhenoAge was a better predictor of adverse outcomes and lethality compared to CA and SpO2 and its predictive capacity was sustained for all age groups. Patients with responses associated to PhenoAgeAccel>0 had higher risk of death and critical illness compared to those with lower values (log-rank p<0.001). Using unsupervised clustering we identified four adaptive responses to SARS-CoV-2 infection: 1) Inflammaging associated with CA, 2) metabolic dysfunction associated with cardio-metabolic comorbidities, 3) unfavorable hematological response, and 4) response associated with favorable outcomes.CONCLUSIONS Adaptive responses related to accelerated aging metrics are linked to adverse COVID-19 outcomes and have unique and distinguishable features. PhenoAge is a better predictor of adverse outcomes compared to CA. | ||
700 | 1 | |a Fermín-Martínez, Carlos A. |e verfasserin |4 aut | |
700 | 1 | |a Antonio-Villa, Neftalí Eduardo |e verfasserin |4 aut | |
700 | 1 | |a Vargas-Vázquez, Arsenio |e verfasserin |4 aut | |
700 | 1 | |a Guerra, Enrique C. |e verfasserin |4 aut | |
700 | 1 | |a Campos-Muñoz, Alejandro |e verfasserin |4 aut | |
700 | 1 | |a Zavala-Romero, Lilian |e verfasserin |4 aut | |
700 | 1 | |a Mehta, Roopa |e verfasserin |4 aut | |
700 | 1 | |a Bahena-López, Jessica Paola |e verfasserin |4 aut | |
700 | 1 | |a Ortiz-Brizuela, Edgar |e verfasserin |4 aut | |
700 | 1 | |a González-Lara, María Fernanda |e verfasserin |4 aut | |
700 | 1 | |a Roman-Montes, Carla M. |e verfasserin |4 aut | |
700 | 1 | |a Martinez-Guerra, Bernardo A. |e verfasserin |4 aut | |
700 | 1 | |a de Leon, Alfredo Ponce |e verfasserin |4 aut | |
700 | 1 | |a Sifuentes-Osornio, José |e verfasserin |4 aut | |
700 | 1 | |a Gutiérrez-Robledo, Luis Miguel |e verfasserin |4 aut | |
700 | 1 | |a Aguilar-Salinas, Carlos A. |e verfasserin |4 aut | |
700 | 1 | |a Bello-Chavolla, Omar Yaxmehen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2020) vom: 27. Nov. |
773 | 1 | 8 | |g year:2020 |g day:27 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.11.03.20225375 |z kostenfrei |3 Volltext |
912 | |a GBV_XBI | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2020 |b 27 |c 11 | ||
953 | |2 045F |a 570 |